Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3SARS-CoV-2에 대한 현재 이용 가능한 인간 중화 항체의 아틀라스 및 Omicron 하위 변이체 BA.1/BA.1.1/BA.2/BA.3에 의한 탈출Article Published on 2022-08-092022-09-11 Journal: Immunity [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] antibody Atla complex COVID-19 decreased activity Efficacy epitope facilitate G446S mutation human monoclonal antibodies Human monoclonal antibody human neutralizing antibodies Immune escape immune escape. immune evasion lack mAb mAbs Mutation Neutralizing neutralizing activities neutralizing antibody Neutralizing assay neutralizing assays omicron Omicron BA.1 Omicron BA.1.1 Omicron BA.2 Omicron BA.3 provided RBD SARS-CoV-2 SARS-CoV-2 RBD sensitivity Seven the SARS-CoV-2 therapeutic Vaccine Vaccines variant variants [DOI] 10.1016/j.immuni.2022.06.005 PMC 바로가기 [Article Type] Article
Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals렉틴 경로 유전자의 생식선 희귀 변이체는 노인에서 무증상 SARS-CoV-2 감염을 일으키기 쉽습니다.Article Published on 2022-08-012022-09-11 Journal: Genetics in medicine : official journal of the Ame [Category] COVID19(2023년), SARS, 변종, [키워드] allelic variant allelic variants Asymptomatic Asymptomatic COVID-19 asymptomatic individual Asymptomatic individuals asymptomatic subject Cohort COLEC10 COLEC11 Collapsing complement complement system COVID-19 decreased activity decreased expression enrichment ES European Evidence exome sequencing data Genes Genetic genetic data Genome Aggregation Database germline Hospitalized hospitalized patient Hyperactivation individual individuals investigated lectin lectin pathway lung tissue MASP1 outcome performed phenotype predicted PROTECT prothrombin rare variant replicated SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2. serum severe COVID-19 severe disease susceptible variant with COVID-19 [DOI] 10.1016/j.gim.2022.04.007 PMC 바로가기 [Article Type] Article
Development of ACE2 autoantibodies after SARS-CoV-2 infectionSARS-COV-2 감염 후 ACE2자가 항체의 발달Research Article Published on 2021-09-032022-08-13 Journal: PLoS ONE [Category] Biochemistry, SARS, 유전자 메커니즘, 진단, 치료기술, [키워드] abundance ACE2 ACE2 antibody ACE2 protein Activation Ang II angiotensin Angiotensin II Angiotensin-converting enzyme angiotensin-converting enzyme 2 Anti-spike antibodies antibody AT1 autoantibodies autoantibody cause cleave convalescent Cutoff decrease decreased activity detectable develop development enzyme enzyme activity exogenous ACE2 Hospitalized Hypothesis immune system implicated increase in Infection inhibit lead less mechanism Outpatient PASC Patient plasma positive PCR test proinflammatory Protein receptor resulting SARS-CoV-2 SARS-COV-2 infection serum soluble ACE2 Symptom tested threshold Trigger triggers [DOI] 10.1371/journal.pone.0257016 PMC 바로가기 [Article Type] Research Article